Multiple Sites

Reference/Study Question

Methods

Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon (Richert-Boe, 1995)

What are the surveillance practices for breast, prostate, and colorectal cancer in Washington and Oregon?

Method: Physician mail survey. Clinical scenarios were presented with options for testing for each cancer site.

Sample: 113 medical oncologists, members of the American Society of Clinical Oncology (ASCO) residing in Washington or Oregon. 105 members were determined to be eligible; RR = 70% (73/105).

Statistical methods: Descriptive statistics.

 

Explanatory variables: Physician age, year of graduation, practice type, state of residence.

Screening for second cancers and osteoporosis in long-term survivors (Mahon et al., 2000) What do nurses know about follow-up of cancer survivors?

Method: Nurse mail survey.

Sample: 321 nurses, members of the Oncology Nursing Society. 321 of 668 outpatient nurses surveyed responded (RR = 48%).

Statistical methods: Descriptive statistics.

 

Explanatory variables: None.

Routine surveillance care after cancer treatment with curative intent (Elston Lafata et al., 2005)

To what extent do post-treatment surveillance practices vary and conform to available guidelines?

Method: Medical record abstraction

Sample: Cohorts of patients aged 30 years or older diagnosed with breast, colorectal, endometrial, lung, or prostate cancer between 1990 and 1995 and treated with curative intent (100 cases for each site). Eligible patients were receiving care from physicians practicing with a 900-member multispecialty, salaried group practice in the Midwest.

 

Statistical methods: Kaplan-Meier estimation

 

Explanatory variables: None.

NOTE: AMA = American Medical Association; ASCO = American Society of Clinical Oncology; AUA = American Urologic Association; CBC = complete blood cell count; CT = computed tomography; DCIS = ductal carcinoma in situ; FOBT = fecal occult blood test; MCO = managed care organization; MRI = magnetic resonance imaging; MSA = Metropolitan Statistical Area; NCCN = National Comprehensive Cancer Network; PET = positron emission tomography; RR = response rate; SEER = Surveillance, Epidemiology, and End Results Program (a cancer registry maintained by NCI); SES = socioeconomic status; TNM = tumor, node, metastasis stage.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement